Search     Contact 
     Members Sign-in 
ABOUT BAYBIOGET INVOLVEDEVENT CENTER





MEMBER CENTERINFORMATION CENTERMEDIA CENTERCAREER CENTER

Therapeutic Breakfast Series

Adaptive Clinical Trial Design and Implementation

Patients, physicians and clinical resources are precious assets to a clinical trial, and it is vital the sponsoring company maximize these assets. To improve clinical research process efficiency and results, the FDA in 2004 proposed The Critical Path Initiative advocating greater use of innovative methods and technologies. The FDA identified adaptive trial designs, e-clinical technologies and biomarker development as key to counter increasingly poor clinical success rates across the industry. Today, these innovations are becoming commonplace within bigger pharma, but how can biotechs and specialty developers take full advantage of these new study approaches? How can you be certain that your clinical strategy is the best one – the strategy with the highest probability of success? Join our panel from small and medium sized companies to discuss real-life experiences for a better understanding of the latest approaches and tools to better guide both study design and execution - even for those on a most cost-conscious budget.

Moderator: Trudy Vanhove, MD, PhD, MBA
Senior Director, Clinical Development, Neurogesx
   
Panel Speakers: Scott Harris, MD
Chief Medical Officer
Ocera Therapeutics, Inc.
Hsiao Dee Lieu, MD, FACC
Vice President of Clinical Research
Nile Therapeutics, Inc.
  Judith Quinlan
Vice President, Adaptive Trials
Cytel Inc.
Todd Reul
Associate Director, Clinical Outsourcing
Facet Biotech
What: Therapeutic Breakfast Series
Planning for Success: Adaptive Clinical Trial Design and Implementation
When: January 28, 2010
8:00 - 10:00am
Where: Wells Fargo Insurance Services Inc.
305 Walnut Street,
Redwood City, CA 94063
Directions
Parking: Free parking
Attire: Business attire suggested
Cost: Early Bird Registration through Jan. 26:
$10.00 - BayBio Members
$20.00 - Non-Members

On-Site Registration, Jan. 28:
$20.00 - BayBio Members
$40.00 - Non-Members
 
Registration
(If you are an employee of a Partner or Sponsor company, please contact
Program Director, Misha Tsirulnikov to obtain your complimentary registration.)
Online Registration
Mail or Fax Registration
  • Pre-registered attendees will receive an immediate receipt/confirmation after submission.
  • Please print this receipt/confirmation and bring it with you to receive your conference credentials.
  • Photo ID (driver's license or passport) will be required at check-in.
  • All sales are final - BayBio offers no refunds

Please mail your event-related questions to: events@baybio.org or you can contact us via phone: 650-871-7101.

Is your company a member? Click here to check.
See how your company can save money by becoming a BayBio member!

Therapeutics Series Sponsors Cytel

Partners

Alexandria Real Estate Equities Amgen Baxter BioMed Reality Trust, Inc.
Biospace Burr Pilger Mayer Burrill and Company Cooley Godward Kronish
Deloitte Touche Tohmatsu DLA Piper Ernest & Young FedEx
Fenwick & West Genencor International Genentech Gilead
KPMG Latham and Watkins Morrison & Foerster Nektar
Oracle Life Sciences Pfizer Roche RoseRyan
Technology Vision Group VWR Wareham Development Wells Fargo

BayBio 400 Oyster Point Blvd. Suite 221 South San Francisco CA 94080 Tel: (650) 871-7101